The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...

The U.S. Food and Drug Administration (USFDA) on Friday approved Merilog as biosimilar to Novolog (insulin aspart) for the ...

Today, the U.S. Food and Drug Administration approved Merilog (insulin-aspart-szjj) as biosimilar to Novolog (insulin aspart) for the improvement of glycemic control in adults and pediatric patients ...

The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...

A recent study reveals that age plays a significant role in the outcomes of intermittent fasting. Researchers from Technical ...

Researchers investigate the underlying mechanisms of endothelial insulin resistance involved in obesity-associated diabetes.

Managing cravings and maintaining a healthy diet can feel overwhelming in today’s fast-paced world. With countless products ...

As Ozempic use rises, some patients report unexpected nasal symptoms, prompting researchers to investigate this new and unusual side effect.

Insulin-like growth factor (IGF ... The main problem, nevertheless, remains the adverse effects experienced with the administration of rhIGF1. The side-effect profile of rhIGF1 has been reduced ...

Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...

Broccoli sprout extract (BSE) modestly lowered fasting blood glucose in prediabetes, but its effectiveness depended on gut ...